Immunomic Therapuetics Inc
Immunomic Therapeutics Inc. is a privately held clinical stage biotechnology company based in Rockville, MD, focused on pioneering nucleic acid immunotherapy platforms. Utilizing their proprietary UNiversal Intracellular Targeted Expression (UNITE) technology, the company aims to develop vaccines that elicit broad immune responses to treat various conditions, with a primary concentration in oncology.
The company's ongoing pipeline includes several innovative therapeutic vaccines under development for cancers such as glioblastoma multiforme and triple-negative breast cancer, as well as initiatives addressing infectious diseases and allergies. Through its investigational technologies, Immunomic Therapeutics strives to improve patient health outcomes and extend lives by harnessing the body's natural immune mechanisms.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


